Literature DB >> 17998860

Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation.

Andre I David1, Gennaro Selvaggi, Phillip Ruiz, Jeffrey J Gaynor, Panagiotis Tryphonopoulos, Gary I Kleiner, Jang I Moon, Seigo Nishida, Peter A Pappas, Lobella Conanan, Debbie Weppler, Violet Esquenazi, David M Levi, Tomoaki Kato, Andreas G Tzakis.   

Abstract

BACKGROUND: Serum citrulline is a marker for acute cellular rejection (ACR) after intestinal transplantation; however, its clinical utility has not yet been established. The goal of this study was to determine clearcut serum levels beyond which the diagnosis of acute rejection could be supported or refuted, and predictors of citrulline levels posttransplant from which more accurate estimates of sensitivity and specificity could be obtained.
METHODS: Since March 2004, we obtained 2135 dried blood spot (DBS) citrulline samples from 57 intestinal transplant recipients at or beyond 3 months posttransplant. Stepwise linear regression was performed to determine the most significant multivariable predictors of the patient's DBS citrulline level.
RESULTS: Seven characteristics were associated with a significantly lower citrulline in multivariable analysis: presence of mild, moderate, or severe ACR; presence of bacteremia or respiratory infection; pediatric age; and time from transplant to DBS sample (P<0.00001 in each case). Using a <13 vs. > or =13 micromoles/L cutoff point, the sensitivity for detecting moderate or severe ACR and the negative predictive value were high (96.4% and >99% respectively). Specificity was 54% to 74% in children and 83% to 88% in adults.
CONCLUSIONS: Citrulline levels <13 micromoles/L should alert the clinical team that a serious problem (rejection or infection) could be looming in a previously stable intestinal recipient. Levels > =13 micromoles/L practically rule out moderate or severe rejection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998860     DOI: 10.1097/01.tp.0000287186.04342.82

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  8 in total

Review 1.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

Review 2.  Immunosuppression Regimens for Intestinal Transplantation in Children.

Authors:  Vikram Kalathur Raghu; Carol G Vetterly; Simon Peter Horslen
Journal:  Paediatr Drugs       Date:  2022-05-23       Impact factor: 3.022

3.  Characterization of T cell immunophenotypes in intestinal transplantation: A pilot study.

Authors:  Marjorie-Anne R Guerra; Maura Rossetti; Zhenyu Zhang; Xinkai Zhou; Emily C Whang; Robert S Venick; Elizabeth A Marcus; Suzanne V McDiarmid; Douglas G Farmer; Elaine F Reed; Laura J Wozniak
Journal:  Transpl Immunol       Date:  2018-09-20       Impact factor: 1.708

Review 4.  Current perspectives on pediatric intestinal transplantation.

Authors:  George V Mazariegos; Robert H Squires; Rakesh K Sindhi
Journal:  Curr Gastroenterol Rep       Date:  2009-06

5.  Determining optimal therapy of dogs with chronic enteropathy by measurement of serum citrulline.

Authors:  Magda Gerou-Ferriani; Rhiannon Allen; Peter-John M Noble; Alexander J German; Marco Caldin; Daniel J Batchelor
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

Review 6.  Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis.

Authors:  Konstantinos C Fragkos; Alastair Forbes
Journal:  United European Gastroenterol J       Date:  2017-10-12       Impact factor: 4.623

7.  Plasma biomarkers of small intestine adaptations in obesity-related metabolic alterations.

Authors:  Catherine Lalande; Jean-Philippe Drouin-Chartier; André J Tremblay; Patrick Couture; Alain Veilleux
Journal:  Diabetol Metab Syndr       Date:  2020-04-09       Impact factor: 3.320

8.  The Proteomic Signature of Intestinal Acute Rejection in the Mouse.

Authors:  Mihai Oltean; Jasmine Bagge; George Dindelegan; Diarmuid Kenny; Antonio Molinaro; Mats Hellström; Ola Nilsson; Carina Sihlbom; Anna Casselbrant; Marcela Davila; Michael Olausson
Journal:  Metabolites       Date:  2021-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.